Roche Holding Valuation
| RHHBY Stock | USD 43.38 0.02 0.05% |
At this time, the company appears to be undervalued. Roche Holding holds a recent Real Value of $48.82 per share. The prevailing price of the company is $43.38. Our model determines the value of Roche Holding from analyzing the company fundamentals such as Operating Margin of 0.32 %, shares outstanding of 6.4 B, and Return On Equity of 0.45 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support acquiring undervalued entities and dropping overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Undervalued
Today
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Roche otc stock is determined by what a typical buyer is willing to pay for full or partial control of Roche Holding Ltd. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche OTC Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 43.38 | Real 48.82 | Hype 43.38 | Naive 43.43 |
The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roche Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Roche Holding Ltd helps investors to forecast how Roche otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors: Roche Holding Total Value Analysis
Roche Holding Ltd is at this time forecasted to have takeover price of 293.22 B with market capitalization of 244.36 B, debt of 16.08 B, and cash on hands of 6.81 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Roche Holding fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
293.22 B | 244.36 B | 16.08 B | 6.81 B |
Roche Holding Investor Information
The company last dividend was issued on the 16th of March 2023. Roche Holding had 2:1 split on the 27th of February 2014. Roche Holding Ltd is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Roche Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Roche Holding has an asset utilization ratio of 68.03 percent. This suggests that the OTC Stock is making $0.68 for each dollar of assets. An increasing asset utilization means that Roche Holding Ltd is more efficient with each dollar of assets it utilizes for everyday operations.Roche Holding Ownership Allocation
Roche Holding owns a total of 6.4 Billion outstanding shares. Roughly 98.73 pct. of Roche Holding outstanding shares are held by general public with 1.27 (%) by third-party entities. On August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Roche Holding's common stock.Roche Holding Profitability Analysis
The company reported the revenue of 62.8 B. Net Income was 13.93 B with profit before overhead, payroll, taxes, and interest of 47.83 B.About Roche Holding Valuation
Our relative valuation model uses a comparative analysis of Roche Holding. We calculate exposure to Roche Holding's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Roche Holding's related companies.Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holdings operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 100920 people.
8 Steps to conduct Roche Holding's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Roche Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Roche Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Roche Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Roche Holding's revenue streams: Identify Roche Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Roche Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Roche Holding's growth potential: Evaluate Roche Holding's management, business model, and growth potential.
- Determine Roche Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Roche Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Roche Holding Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 854.3 M | |
| Quarterly Earnings Growth Y O Y | -0.326 | |
| Forward Price Earnings | 14.4718 | |
| Retained Earnings | 34.2 B |
Additional Tools for Roche OTC Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.